SANOBER MALIK MD
Prescription History 1891835708
Internal Medicine in Norman, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SANOBER MALIK MD, an active Internal Medicine specialist practicing in Norman, OK. Our medical registry currently tracks 39 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,373 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydroxychloroquine Sulfate, which accounts for 533 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Hydroxychloroquine Sulfate | 533 | $33.65▼ below OK avg | ▲ More than typical |
About Hydroxychloroquine Sulfate: Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. Show more ▾ The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits. A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) In 2024, this provider wrote 533 Medicare prescriptions for Hydroxychloroquine Sulfate, about 6.5 times the volume of the typical Oklahoma prescriber of this medication (82.1). Medicare paid an average of $33.65 per fill, versus $44.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 1,184.7 30-Day Fills standardized to 30-day supplies 35,499 Days of Medication total across all patients in 2024 | |||
| Prednisone | 426 | $4.12 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 426 Medicare prescriptions for Prednisone, about 9.3 times the volume of the typical Oklahoma prescriber of this medication (45.6). Medicare paid an average of $4.12 per fill, versus $3.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 477 30-Day Fills standardized to 30-day supplies 10,264 Days of Medication total across all patients in 2024 | |||
| MethotrexateMethotrexate Sodium | 342 | $20.27▼ below OK avg | ▲ More than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma), severe psoriasis that has not responded to other treatments, or rheumatoid arthritis. Show more ▾ It may also be used to treat a certain type of arthritis in children (polyarticular juvenile idiopathic arthritis - pJIA). Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and blocking the immune system from attacking healthy tissue. Early treatment of rheumatoid arthritis with methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2024, this provider wrote 342 Medicare prescriptions for Methotrexate, about 4.3 times the volume of the typical Oklahoma prescriber of this medication (78.7). Medicare paid an average of $20.27 per fill, versus $24.40 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 588.5 30-Day Fills standardized to 30-day supplies 17,328 Days of Medication total across all patients in 2024 | |||
| Sulfasalazine | 197 | $19.69▼ below OK avg | ▲ More than typical |
About Sulfasalazine: Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. Show more ▾ This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs). A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) In 2024, this provider wrote 197 Medicare prescriptions for Sulfasalazine, about 5 times the volume of the typical Oklahoma prescriber of this medication (39.4). Medicare paid an average of $19.69 per fill, versus $23.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 312 30-Day Fills standardized to 30-day supplies 9,346 Days of Medication total across all patients in 2024 | |||
| Enbrel SureclickEtanercept | 172 | $8,037.75 | ▲ More than typical |
About Enbrel Sureclick: This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Show more ▾ Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. In 2024, this provider wrote 172 Medicare prescriptions for Enbrel Sureclick, about 3.9 times the volume of the typical Oklahoma prescriber of this medication (43.9). Medicare paid an average of $8,037.75 per fill, versus $7,836.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 182.8 30-Day Fills standardized to 30-day supplies 5,172 Days of Medication total across all patients in 2024 | |||
| Humira(Cf) PenAdalimumab | 146 | $7,481.51▼ below OK avg | ▲ More than typical |
About Humira(Cf) Pen: Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). This monograph is about the following adalimumab products: adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk. A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2024, this provider wrote 146 Medicare prescriptions for Humira(Cf) Pen, about 3.6 times the volume of the typical Oklahoma prescriber of this medication (40.6). Medicare paid an average of $7,481.51 per fill, versus $8,556.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 156.5 30-Day Fills standardized to 30-day supplies 4,430 Days of Medication total across all patients in 2024 | |||
| Tramadol Hcl | 146 | $12.32 | ▲ More than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2024, this provider wrote 146 Medicare prescriptions for Tramadol Hcl, about 2.3 times the volume of the typical Oklahoma prescriber of this medication (63.5). Medicare paid an average of $12.32 per fill, versus $9.16 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 146 30-Day Fills standardized to 30-day supplies 4,116 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 137 | $31.47 | ≈ Typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 137 Medicare prescriptions for Gabapentin, about 1.2 times the volume of the typical Oklahoma prescriber of this medication (114.8). Medicare paid an average of $31.47 per fill, versus $16.87 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 323.7 30-Day Fills standardized to 30-day supplies 9,710 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 107 | $6.06▼ below OK avg | ▲ More than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 107 Medicare prescriptions for Alendronate Sodium, about 2.4 times the volume of the typical Oklahoma prescriber of this medication (45.5). Medicare paid an average of $6.06 per fill, versus $10.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 212.6 30-Day Fills standardized to 30-day supplies 6,286 Days of Medication total across all patients in 2024 | |||
| Azathioprine | 100 | $29.04▼ below OK avg | ▲ More than typical |
About Azathioprine: Azathioprine is used to prevent organ rejection in people who have received a kidney transplant. Show more ▾ It is usually taken along with other medications to allow your new kidney to function normally. Azathioprine is also used to treat rheumatoid arthritis. In this condition, the body's defense system (immune system) attacks healthy joints. Azathioprine belongs to a class of drugs known as immunosuppressants. It works by weakening the immune system to help your body accept the new kidney as if it were your own (in the case of an organ transplant) or to prevent further damage to your joints (in the case of rheumatoid arthritis). Talk to your doctor about the risks and benefits of azathioprine, especially when used by children and young adults. An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) In 2024, this provider wrote 100 Medicare prescriptions for Azathioprine, about 3.1 times the volume of the typical Oklahoma prescriber of this medication (32.7). Medicare paid an average of $29.04 per fill, versus $40.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 171.5 30-Day Fills standardized to 30-day supplies 5,141 Days of Medication total across all patients in 2024 | |||
| Methocarbamol | 90 | $9.57▼ below OK avg | ▲ More than typical |
About Methocarbamol: Methocarbamol is used to treat muscle spasms/pain. Show more ▾ It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles. A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206) In 2024, this provider wrote 90 Medicare prescriptions for Methocarbamol, about 2.8 times the volume of the typical Oklahoma prescriber of this medication (31.7). Medicare paid an average of $9.57 per fill, versus $14.02 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 133 30-Day Fills standardized to 30-day supplies 3,955 Days of Medication total across all patients in 2024 | |||
| Allopurinol | 77 | $16.84 | ▲ More than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2024, this provider wrote 77 Medicare prescriptions for Allopurinol, about 1.5 times the volume of the typical Oklahoma prescriber of this medication (51.4). Medicare paid an average of $16.84 per fill, versus $10.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 202.7 30-Day Fills standardized to 30-day supplies 6,080 Days of Medication total across all patients in 2024 | |||
| Meloxicam | 67 | $5.65▼ below OK avg | ≈ Typical |
About Meloxicam: Meloxicam is used to treat arthritis. Show more ▾ It reduces pain, swelling, and stiffness of the joints. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS. In 2024, this provider wrote 67 Medicare prescriptions for Meloxicam, about the same volume as the typical Oklahoma prescriber of this medication (63.2). Medicare paid an average of $5.65 per fill, versus $7.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 166 30-Day Fills standardized to 30-day supplies 4,980 Days of Medication total across all patients in 2024 | |||
| Pregabalin | 66 | $31.02 | ≈ Typical |
About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾ This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. In 2024, this provider wrote 66 Medicare prescriptions for Pregabalin, about the same volume as the typical Oklahoma prescriber of this medication (58.9). Medicare paid an average of $31.02 per fill, versus $23.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 78 30-Day Fills standardized to 30-day supplies 2,310 Days of Medication total across all patients in 2024 | |||
| Orencia ClickjectAbatacept | 66 | $6,733.18 | ▲ More than typical |
About Orencia Clickject: This medication is used to treat rheumatoid arthritis, a condition in which the body's own defense system (immune system) attacks healthy tissue. Show more ▾ This leads to swelling in the joints, which causes pain and makes it harder to move. Abatacept works by weakening your immune system. This effect helps to slow down joint damage and reduce joint pain and swelling so you can move better. This medication is also used to treat other types of arthritis (such as juvenile idiopathic arthritis, psoriatic arthritis). A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. In 2024, this provider wrote 66 Medicare prescriptions for Orencia Clickject, about 2.4 times the volume of the typical Oklahoma prescriber of this medication (27.7). Medicare paid an average of $6,733.18 per fill, versus $5,930.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 75.9 30-Day Fills standardized to 30-day supplies 2,156 Days of Medication total across all patients in 2024 | |||
| Actemra ActpenTocilizumab | 59 | $4,295.71 | ▲ More than typical |
About Actemra Actpen: This medication is used to treat rheumatoid arthritis in adults and in children (such as polyarticular juvenile idiopathic arthritis-PJIA, systemic juvenile idiopathic arthritis-SJIA). Show more ▾ It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab is used to treat giant cell arteritis. It helps to reduce swelling in your blood vessels so blood can flow more easily. This medication is also used to slow down the decrease in lung function in people with a certain type of lung disease (systemic sclerosis-associated interstitial lung disease - SSc-ILD). Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation). This monograph is about the following tocilizumab products: tocilizumab and tocilizumab-aazg. A humanised anti-interleukin-6 receptor monoclonal antibody. In 2024, this provider wrote 59 Medicare prescriptions for Actemra Actpen, about 2.6 times the volume of the typical Oklahoma prescriber of this medication (23). Medicare paid an average of $4,295.71 per fill, versus $3,945.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64.4 30-Day Fills standardized to 30-day supplies 1,820 Days of Medication total across all patients in 2024 | |||
| Duloxetine Hcl | 51 | $34.15 | ≈ Typical |
About Duloxetine Hcl: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ It is also used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. In 2024, this provider wrote 51 Medicare prescriptions for Duloxetine Hcl, about 85% of the volume of the typical Oklahoma prescriber of this medication (60.2). Medicare paid an average of $34.15 per fill, versus $27.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 137 30-Day Fills standardized to 30-day supplies 4,064 Days of Medication total across all patients in 2024 | |||
| Celecoxib | 49 | $40.00 | ≈ Typical |
About Celecoxib: This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). Show more ▾ It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling. A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN. In 2024, this provider wrote 49 Medicare prescriptions for Celecoxib, about the same volume as the typical Oklahoma prescriber of this medication (45.2). Medicare paid an average of $40.00 per fill, versus $33.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 109 30-Day Fills standardized to 30-day supplies 3,255 Days of Medication total across all patients in 2024 | |||
| BenlystaBelimumab | 49 | $5,057.27 | ▲ More than typical |
About Benlysta: This medication is used with other medications to treat certain types of lupus. Show more ▾ Belimumab belongs to a class of drugs known as monoclonal antibodies. It works by decreasing the effect of a certain protein that is increased in people with active lupus. This may help decrease some of the symptoms of lupus. Monoclonal antibody directed against human BLyS protein (B lymphocyte stimulator) for treatment of autoimmune diseases. In 2024, this provider wrote 49 Medicare prescriptions for Benlysta, about 2 times the volume of the typical Oklahoma prescriber of this medication (24.8). Medicare paid an average of $5,057.27 per fill, versus $4,527.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,396 Days of Medication total across all patients in 2024 | |||
| KevzaraSarilumab | 45 | $5,574.79 | ▲ More than typical |
About Kevzara: This medication is used to treat rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (pJIA), or polymyalgia rheumatica (PMR). Show more ▾ Sarilumab belongs to a class of drugs known as monoclonal antibodies. It helps reduce pain and swelling by blocking Interleukin-6, a substance made by the body that causes swelling (inflammation). Antibody against IL-6Ralpha in patients with rheumatoid arthritis. In 2024, this provider wrote 45 Medicare prescriptions for Kevzara, about 2.3 times the volume of the typical Oklahoma prescriber of this medication (19.8). Medicare paid an average of $5,574.79 per fill, versus $4,634.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.5 30-Day Fills standardized to 30-day supplies 1,652 Days of Medication total across all patients in 2024 | |||
| XeljanzTofacitinib Citrate | 40 | $5,630.00▼ below OK avg | ▲ More than typical |
About Xeljanz: Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis-pcJIA). Show more ▾ It helps to decrease pain/tenderness/swelling in the joints. Tofacitinib is also used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. In 2024, this provider wrote 40 Medicare prescriptions for Xeljanz, about 2.2 times the volume of the typical Oklahoma prescriber of this medication (18.4). Medicare paid an average of $5,630.00 per fill, versus $5,667.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2024 | |||
| Mycophenolate Mofetil | 39 | $398.94 | ≈ Typical |
About Mycophenolate Mofetil: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2024, this provider wrote 39 Medicare prescriptions for Mycophenolate Mofetil, about the same volume as the typical Oklahoma prescriber of this medication (36.9). Medicare paid an average of $398.94 per fill, versus $106.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2024 | |||
| Folic Acid | 37 | $7.06▼ below OK avg | ▲ More than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2024, this provider wrote 37 Medicare prescriptions for Folic Acid, about 1.4 times the volume of the typical Oklahoma prescriber of this medication (27.3). Medicare paid an average of $7.06 per fill, versus $7.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 79 30-Day Fills standardized to 30-day supplies 2,370 Days of Medication total across all patients in 2024 | |||
| Tizanidine Hcl | 37 | $22.16 | ▼ Less than typical |
About Tizanidine Hcl: This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). Show more ▾ It works by helping to relax the muscles. In 2024, this provider wrote 37 Medicare prescriptions for Tizanidine Hcl, about 65% of the volume of the typical Oklahoma prescriber of this medication (56.6). Medicare paid an average of $22.16 per fill, versus $12.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 104.7 30-Day Fills standardized to 30-day supplies 3,142 Days of Medication total across all patients in 2024 | |||
| RinvoqUpadacitinib | 29 | $7,569.02 | ≈ Typical |
About Rinvoq: Upadacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis- pJIA). Show more ▾ It helps decrease pain, tenderness, and swelling in the joints. Upadacitinib is also used to treat a skin condition called atopic dermatitis. It reduces swelling, itching, and redness in the skin. This medication may also be used to treat certain bowel diseases (Crohn's disease, ulcerative colitis). It helps to reduce symptoms such as diarrhea and stomach pain. A JAK-1 inhibitor; for treatment of rheumatoid arthritis. In 2024, this provider wrote 29 Medicare prescriptions for Rinvoq, about 82% of the volume of the typical Oklahoma prescriber of this medication (35.3). Medicare paid an average of $7,569.02 per fill, versus $6,678.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| Sulfasalazine DrSulfasalazine | 29 | $18.04▼ below OK avg | ▼ Less than typical |
About Sulfasalazine Dr: Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. Show more ▾ This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs). A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) In 2024, this provider wrote 29 Medicare prescriptions for Sulfasalazine Dr, about half the volume of the typical Oklahoma prescriber of this medication (65.4). Medicare paid an average of $18.04 per fill, versus $33.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| Humira(Cf)Adalimumab | 29 | $6,879.70▼ below OK avg | ▲ More than typical |
About Humira(Cf): Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). This monograph is about the following adalimumab products: adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk. A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2024, this provider wrote 29 Medicare prescriptions for Humira(Cf), about 1.6 times the volume of the typical Oklahoma prescriber of this medication (17.6). Medicare paid an average of $6,879.70 per fill, versus $8,557.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 29 30-Day Fills standardized to 30-day supplies 816 Days of Medication total across all patients in 2024 | |||
| Methylprednisolone | 28 | $8.81 | ≈ Typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2024, this provider wrote 28 Medicare prescriptions for Methylprednisolone, about 79% of the volume of the typical Oklahoma prescriber of this medication (35.4). Medicare paid an average of $8.81 per fill, versus $8.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 170 Days of Medication total across all patients in 2024 | |||
| Humira PenAdalimumab | 24 | $6,713.53▼ below OK avg | ▲ More than typical |
About Humira Pen: Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). This monograph is about the following adalimumab products: adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk. A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2024, this provider wrote 24 Medicare prescriptions for Humira Pen, about 1.4 times the volume of the typical Oklahoma prescriber of this medication (17.6). Medicare paid an average of $6,713.53 per fill, versus $7,934.00 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 24 30-Day Fills standardized to 30-day supplies 672 Days of Medication total across all patients in 2024 | |||
| Cyclobenzaprine Hcl | 21 | $9.68▼ below OK avg | ▼ Less than typical |
About Cyclobenzaprine Hcl: Cyclobenzaprine is used short-term to treat muscle spasms. Show more ▾ It is usually used along with rest and physical therapy. It works by helping to relax the muscles. Lisseril is synonymous for HCl; structure. In 2024, this provider wrote 21 Medicare prescriptions for Cyclobenzaprine Hcl, about half the volume of the typical Oklahoma prescriber of this medication (48.1). Medicare paid an average of $9.68 per fill, versus $10.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 53 30-Day Fills standardized to 30-day supplies 1,590 Days of Medication total across all patients in 2024 | |||
| SimponiGolimumab | 21 | $5,992.73▼ below OK avg | ≈ Typical |
About Simponi: This medication is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, and ankylosing spondylitis). Show more ▾ It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage. By reducing joint swelling, the medication helps to reduce further joint damage and preserve joint function. Depending on the type of arthritis that is being treated, this drug may be used alone or in combination with another drug called methotrexate. This medication is also used to treat a certain bowel condition (ulcerative colitis). It is used to help lessen symptoms of moderate to severe ulcerative colitis (such as abdominal pain/cramping, diarrhea, bloody stools). Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX. In 2024, this provider wrote 21 Medicare prescriptions for Simponi, about the same volume as the typical Oklahoma prescriber of this medication (20.3). Medicare paid an average of $5,992.73 per fill, versus $6,654.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Teriparatide | 19 | $1,983.48▼ below OK avg | ▲ More than typical |
About Teriparatide: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 19 Medicare prescriptions for Teriparatide, about 1.3 times the volume of the typical Oklahoma prescriber of this medication (15). Medicare paid an average of $1,983.48 per fill, versus $2,358.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 19 30-Day Fills standardized to 30-day supplies 536 Days of Medication total across all patients in 2024 | |||
| Leflunomide | 19 | $27.24▼ below OK avg | ▼ Less than typical |
About Leflunomide: This medication is used to treat rheumatoid arthritis, a condition in which the body's defense system (immune system) fails to recognize the body as itself and attacks the healthy tissues around the joints. Show more ▾ Leflunomide helps to reduce the joint damage/pain/swelling and helps you to move better. It works by weakening your immune system and decreasing swelling (inflammation). An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. In 2024, this provider wrote 19 Medicare prescriptions for Leflunomide, about a quarter of the volume of the typical Oklahoma prescriber of this medication (75.6). Medicare paid an average of $27.24 per fill, versus $61.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| Xeljanz XrTofacitinib Citrate | 15 | $5,672.75▼ below OK avg | ▼ Less than typical |
About Xeljanz Xr: Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis). Show more ▾ It helps to decrease pain/tenderness/swelling in the joints. Tofacitinib is also used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. In 2024, this provider wrote 15 Medicare prescriptions for Xeljanz Xr, about half the volume of the typical Oklahoma prescriber of this medication (26.5). Medicare paid an average of $5,672.75 per fill, versus $5,835.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Febuxostat | 14 | $135.23 | ≈ Typical |
About Febuxostat: Febuxostat is used to lower uric acid levels in people with gout. Show more ▾ Febuxostat works by reducing the amount of uric acid made by the body. An increased uric acid level can cause gout. Because of the risk of very serious heart-related problems and stroke with febuxostat (see also Warning section), febuxostat should be used only after treatment with a medication called allopurinol did not work to lower your uric acid level, caused serious side effects, or is not recommended by your doctor. Febuxostat should be used only if you have symptoms caused by a high blood uric acid level. A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT. In 2024, this provider wrote 14 Medicare prescriptions for Febuxostat, about 78% of the volume of the typical Oklahoma prescriber of this medication (18.1). Medicare paid an average of $135.23 per fill, versus $84.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.5 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| ForteoTeriparatide | 13 | $4,318.38 | ≈ Typical |
About Forteo: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 13 Medicare prescriptions for Forteo, about 86% of the volume of the typical Oklahoma prescriber of this medication (15.2). Medicare paid an average of $4,318.38 per fill, versus $4,265.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| Clobetasol Propionate | 12 | $29.18▼ below OK avg | ▼ Less than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2024, this provider wrote 12 Medicare prescriptions for Clobetasol Propionate, about a third of the volume of the typical Oklahoma prescriber of this medication (40.6). Medicare paid an average of $29.18 per fill, versus $48.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 12 30-Day Fills standardized to 30-day supplies 307 Days of Medication total across all patients in 2024 | |||
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $5,668.12▼ below OK avg | ▼ Less than typical |
About Cosentyx Sensoready (2 Pens): This medication is used to treat plaque psoriasis and certain types of arthritis (such as arthritis of the spine, psoriatic arthritis, axial spondyloarthritis, enthesitis-related arthritis). Show more ▾ It is also used to treat a certain skin disorder (hidradenitis suppurativa). Secukinumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. A fully human antibody to interleukin-17A for treatment of psoriasis, rheumatoid arthritis, and uveitis. In 2024, this provider wrote 11 Medicare prescriptions for Cosentyx Sensoready (2 Pens), about half the volume of the typical Oklahoma prescriber of this medication (19.2). Medicare paid an average of $5,668.12 per fill, versus $7,604.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 11 30-Day Fills standardized to 30-day supplies 326 Days of Medication total across all patients in 2024 | |||
| Vitamin D2Ergocalciferol (Vitamin D2) | 11 | $11.13 | ▼ Less than typical |
About Vitamin D2: Vitamin D (ergocalciferol-D2, cholecalciferol-D3, alfacalcidol) is a fat-soluble vitamin that helps your body absorb calcium and phosphorus. Show more ▾ Having the right amount of vitamin D, calcium, and phosphorus is important for building and keeping strong bones. Vitamin D is used to treat and prevent bone disorders (such as rickets, osteomalacia). Vitamin D is made by the body when skin is exposed to sunlight. Sunscreen, protective clothing, limited exposure to sunlight, dark skin, and age may prevent getting enough vitamin D from the sun. Vitamin D with calcium is used to treat or prevent bone loss (osteoporosis). Vitamin D is also used with other medications to treat low levels of calcium or phosphate caused by certain disorders (such as hypoparathyroidism, pseudohypoparathyroidism, familial hypophosphatemia). It may be used in kidney disease to keep calcium levels normal and allow normal bone growth. Vitamin D drops (or other supplements) are given to breastfed infants because breast milk usually has low levels of vitamin D. Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. In 2024, this provider wrote 11 Medicare prescriptions for Vitamin D2, about a third of the volume of the typical Oklahoma prescriber of this medication (27.3). Medicare paid an average of $11.13 per fill, versus $10.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.8 30-Day Fills standardized to 30-day supplies 684 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for SANOBER MALIK MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Norman, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
